Related Experiment Video
Updated: May 12, 2026
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Case Report: FAPI PET/CT detected occult contralateral DCIS and supraclavicular metastasis, guiding neoadjuvant
1Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Background:
Accurate staging is critical for breast cancer management. While [18F]FDG PET/CT is the standard for metabolic imaging, it has limitations in detecting tumors with low glucose metabolism and small regional metastases. Fibroblast activation protein inhibitor (FAPI) PET/CT targets cancer-associated fibroblasts and offers a novel diagnostic avenue.
Case Presentation:
A female patient presented with left-sided inflammatory breast cancer. Conventional [18F]FDG PET/CT showed uptake in the left breast but missed regional spread and contralateral disease. Conversely, a supplemental [18F]AlF-NOTA-FAPI-04 PET/CT revealed intense uptake in the left breast (SUVmax 19.45) and detected occult metastases in the left axillary (SUVmax 15.12) and supraclavicular lymph nodes (SUVmax 14.83). Crucially, it also identified a high-uptake lesion in the right breast (SUVmax 15.06), which biopsy confirmed as DCIS, upstaging the diagnosis to synchronous bilateral breast cancer. Following neoadjuvant chemotherapy, follow-up FAPI PET/CT demonstrated that uptake in the supraclavicular and axillary nodes dropped to background levels, predicting a complete response (CR). Postoperative pathology confirmed CR in the lymph nodes.
Conclusion:
This case highlights the superior sensitivity of FAPI PET/CT over FDG PET/CT in detecting low-metabolic malignancies like DCIS and accurately staging regional nodal involvement (including supraclavicular nodes). FAPI PET/CT played a decisional role in upstaging the patient and monitoring neoadjuvant therapy response.
